At the experimental endpoint, 15 weeks after the initial AOM injection, macroscopic evaluation of dissected and washed colons indicated the development of well-defined tumours in WT and Casp11−/−-treated mice (Fig. 1c). The gene discussed is SCAF11; the disease is neoplasm.